Adage Capital Partners Gp, L.L.C. Natera, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $17.3 Million - $23.8 Million	-200,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$100.17 - $126.36 $2.5 Million - $3.16 Million	25,000 Added 14.29%	200,000 $22.3 Million
Q2 2021 Aug 16, 2021	BUY	$86.05 - $119.72 $4.3 Million - $5.99 Million	50,000 Added 40.0%	175,000 $19.9 Million
Q1 2021 May 17, 2021	SELL	$91.47 - $124.36 $22.9 Million - $31.1 Million	-250,000 Reduced 66.67%	125,000 $12.7 Million
Q4 2020 Feb 16, 2021	SELL	$66.66 - $111.74 $6.67 Million - $11.2 Million	-100,000 Reduced 21.05%	375,000 $37.3 Million
Q3 2020 Nov 16, 2020	BUY	$45.89 - $72.67 $4.59 Million - $7.27 Million	100,000 Added 26.67%	475,000 $34.3 Million
Q2 2020 Aug 14, 2020	BUY	$26.36 - $49.86 $9.89 Million - $18.7 Million	375,000 New	375,000 $18.7 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $14.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.